The A+/N+ subgroup had higher CVD risk than other subgroups despite a better cardiometabolic profile (less diabetes, less hypertension, higher HDL-C, lower triglycerides, lower BMI, lower waist-to-hip ratio, lower body fat percentage) than those with lower adiponectin levels (Central Illustration). This evidence concerns the gene ADIPOQ and Hypertension.